Prescription Drug Monitoring Programs
"Prescription Drug Monitoring Programs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.
Descriptor ID |
D000073958
|
MeSH Number(s) |
E05.337.800.800 N02.421.668.320.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drug Monitoring Programs".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drug Monitoring Programs".
This graph shows the total number of publications written about "Prescription Drug Monitoring Programs" by people in this website by year, and whether "Prescription Drug Monitoring Programs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 2 | 0 | 2 |
2020 | 3 | 0 | 3 |
2021 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Drug Monitoring Programs" by people in Profiles.
-
High-risk opioid analgesic dispensing to adolescents 12-18?years old in South Carolina: 2010-2017. Pharmacoepidemiol Drug Saf. 2022 03; 31(3):353-360.
-
High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018. J Public Health Manag Pract. 2021 Jul-Aug 01; 27(4):379-384.
-
Academic detailing increases prescription drug monitoring program use among primary care practices. J Am Pharm Assoc (2003). 2021 Jul-Aug; 61(4):418-424.e2.
-
Opioid Use Among Individuals With Spinal Cord Injury: Prevalence Estimates Based on State Prescription Drug Monitoring Program Data. Arch Phys Med Rehabil. 2021 05; 102(5):828-834.
-
Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates. South Med J. 2020 09; 113(9):415-417.
-
The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):559-564.
-
Prescription Drug Monitoring Program Use: National Dental PBRN Results. JDR Clin Trans Res. 2019 04; 4(2):178-186.
-
Opioid prescribing and risk mitigation implementation in the management of acute?pain: Results from The National Dental Practice-Based Research Network. J Am Dent Assoc. 2018 May; 149(5):353-362.
-
Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians. J Contin Educ Health Prof. 2017; 37(2):98-105.
-
Dental opioid prescribing and multiple opioid prescriptions among dental patients: Administrative data from the South Carolina prescription drug monitoring program. J Am Dent Assoc. 2016 07; 147(7):537-44.